Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

EW - Edwards Lifesciences Corp


Close
75.3
4.690   6.228%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:01:26 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%

$70.61
4.69
6.64%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
72%
Profitability 100%
Dept financing 18%
Liquidity 42%
Performance 67%
Company vs Stock growth
vs
Performance
5 Days
0.76%
1 Month
5.77%
3 Months
15.24%
6 Months
-17.24%
1 Year
-0.59%
2 Year
1.60%
Key data
Stock price
$75.30
P/E Ratio 
28.58
DAY RANGE
$70.61 - $75.04
EPS 
$2.43
52 WEEK RANGE
$62.04 - $96.12
52 WEEK CHANGE
-$1.09
MARKET CAP 
42.144 B
YIELD 
N/A
SHARES OUTSTANDING 
602.400 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
BETA 
1.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$7,090,003
AVERAGE 30 VOLUME 
$5,478,291
Company detail
CEO: Michael A. Mussallem
Region: US
Website: edwards.com
Employees: 17,300
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, critical care and surgical monitoring. It offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name. The company distributes its products through a direct sales force and independent distributors.

Recent news